Prenalterol — CAS 57526-81-5

Prenalterol is a selective beta-1 adrenergic receptor agonist with positive inotropic effects on the heart. It increases cardiac contractility without significantly affecting heart rate, making it a cardioselective agent investigated for acute and chronic heart failure. Mediocon Inc manufactures Prenalterol API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Investigational use in acute and chronic congestive heart failure
• Research into beta-1 selective adrenergic agonism for cardiology
• Used as a reference standard in cardiac pharmacology research
• Potential use in cardiogenic shock and low cardiac output states

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support